VIC Team

VIC Team

Recent Posts

VIC Fellows Spotlight: Michael Gaspar, MD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Zebra Analytix Appoints John A. Michalek as CEO

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that John A. Michalek has joined the company as Chief Executive Officer and Board Member to lead the...

Behind the Curtain | Single Family Offices and ESG Investing with Brian Cork

Brian Patrick Cork is a principal of brian cork COACHING™, which provides client services in business design, strategy development, executive team-building, and financial capital formation. Please tell us a little about...

VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC adds two life science leaders, bringing additional key insight to the team. VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively...

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

Atkins will bring critical insight into the development and commercialization of inhaled medicines Albuquerque, NM - Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC Adds Acclaimed Life Science Veteran to Their Team. Fayetteville, AR - VIC Technology Venture Development announced today the appointment of Fenel M. Eloi, a seasoned executive in the life science sector, to their...

Inside CU Innovations: An Interview with Executive Director, Kim Muller

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. We recently had a chance to...

Zebra Analytix Receives NIH Grant for Rapid Breath Detection of Hazardous Substance Exposure

FAYETTEVILLE, AR - Zebra Analytix, Inc.—a VIC Technology Venture Development portfolio company—announced today that it has been awarded a National Institutes of Health (NIH) Small Business Innovation Research (SBIR)...

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

VIC Foundry, in collaboration with Sandia National Laboratories, is developing a self-contained isothermal nucleic acid amplification test to address an unmet need for at-home testing of COVID-19 infection. This...

VIC 2020 Annual Report Executive Summary

Despite the challenges 2020 brought, we saw promising progress for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.


Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Protecting Early Investors in Capital-Intensive Life Science Companies
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
VIC 2021 Mid-Year Update Executive Summary
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission